Send to

Choose Destination
Genome Announc. 2015 Nov 5;3(6). pii: e01272-15. doi: 10.1128/genomeA.01272-15.

Complete Genome Sequence of Multidrug-Resistant Clinical Isolate Mycobacterium tuberculosis 187.0, Used To Study the Effect of Drug Susceptibility Reversion by the New Medicinal Drug FS-1.

Author information

Scientific Center for Anti-Infectious Drugs (SCAID), Almaty, Kazakhstan.
Scientific Center for Anti-Infectious Drugs (SCAID), Almaty, Kazakhstan
Center of Bioinformatics and Computational Biology (CBCB), Department of Biochemistry, University of Pretoria, Pretoria, South Africa.


Complete genome sequence of the multidrug-resistant clinical isolate Mycobacterium tuberculosis SCAID 187.0 containing several drug-resistance mutations is presented. This strain is used in experiments to study genomic and population changes leading to reversion of susceptibility to the 1st line anti-tuberculosis (TB) drugs under the influence of a new medicinal drug FS-1.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center